BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 4273095)

  • 1. Mithramycin therapy in Paget's disease.
    Russell AS; Lentle BC
    Can Med Assoc J; 1974 Feb; 110(4):397-400. PubMed ID: 4273095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mithramycin in the treatment of Paget's disease of bone.
    Elias EG; Evans JT
    J Bone Joint Surg Am; 1972 Dec; 54(8):1730-6. PubMed ID: 4265871
    [No Abstract]   [Full Text] [Related]  

  • 3. [Non-hormonal drug treatment in Paget's disease].
    Ryckewaert A; Lemaire V; Tubiana M
    Rev Rhum Mal Osteoartic; 1975 Nov; 42(11):693-8. PubMed ID: 131365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of 10 cases of symptomatic Paget's disease with etidronate (EHDP)].
    Jung A; Mermillod B; Schenk R; Courvoisier B; Burkhardt P; Epiney J; Fleisch
    Schweiz Med Wochenschr; 1976 Nov; 106(48):1667-73. PubMed ID: 827810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of sodium etidronate in the treatment of Paget's disease of bone. Osteitis deformans.
    Stein I; Shapiro B; Ostrum B; Beller ML
    Clin Orthop Relat Res; 1977; (122):347-58. PubMed ID: 402246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ascorbic acid therapy for the relief of bone pain in Paget's disease.
    Basu TK; Smethurst M; Gillett MB; Donaldson D; Jordan SJ; Williams DC; Hicklin JA
    Acta Vitaminol Enzymol; 1978; 32(1-4):45-9. PubMed ID: 582875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Paget disease of the skeleton. Internal medicine aspects].
    Ziegler R; Baldauf G
    Radiologe; 1984 Sep; 24(9):401-7. PubMed ID: 6238341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mithramycin in Paget's disease.
    Epstein S
    S Afr Med J; 1974 Jun; 48(31):1328-30. PubMed ID: 4276946
    [No Abstract]   [Full Text] [Related]  

  • 9. Long term effectiveness of low dose mithramycin for Paget's disease of bone.
    Russell AS; Chalmers IM; Percy JS; Lentle BC
    Arthritis Rheum; 1979 Mar; 22(3):215-8. PubMed ID: 154331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical and metabolic effects of mithramycin and glucagon in the treatment of Paget's disease].
    Hadjipavlou AG; Danais S; Greenwood F; Siller TN; Tsoukas GM
    Union Med Can; 1978 Sep; 107(9):849-56. PubMed ID: 151960
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of Paget's disease of bone with ethane-1 hydroxy-1, 1 diphosphonate at low dosage (author's transl)].
    Alexandre C; Chapuy MC; Bressot C; Vignon E; Arlot M; Mathieu L; Edouard C; Johnston CC; Meunier PJ
    Nouv Presse Med; 1980 Nov; 9(45):3429-33. PubMed ID: 6777752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of Paget's disease with mithramycin: further experiences.
    Ryan WG; Schwartz TB; Northrop G
    Semin Drug Treat; 1972; 2(1):57-64. PubMed ID: 4261785
    [No Abstract]   [Full Text] [Related]  

  • 13. [Biological exploration of Paget's disease].
    Eisinger J; Laponche AM; Roux H; Recordier AM
    Rev Rhum Mal Osteoartic; 1976 Feb; 43(2):105-11. PubMed ID: 131366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of urinary excretion of nonisomerized and beta-isomerized forms of type I collagen breakdown products to monitor the effects of the bisphosphonate zoledronate in Paget's disease.
    Garnero P; Gineyts E; Schaffer AV; Seaman J; Delmas PD
    Arthritis Rheum; 1998 Feb; 41(2):354-60. PubMed ID: 9485094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic progress--review VII. The medical treatment of Paget's disease.
    Sheppard MC
    J Clin Hosp Pharm; 1983 Mar; 8(1):35-44. PubMed ID: 6221033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Newer agents in treating Paget's disease of bone.
    Goldfield EB
    Geriatrics; 1974 Dec; 29(12):61-9. PubMed ID: 4279196
    [No Abstract]   [Full Text] [Related]  

  • 17. Determinants of remission of Paget's disease of bone.
    Patel S; Stone MD; Coupland C; Hosking DJ
    J Bone Miner Res; 1993 Dec; 8(12):1467-73. PubMed ID: 8304048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Control of osteitis deformans using glucagon, calcitonin, and mithramycin.
    Condon JR; Surtees J; Robinson V
    Postgrad Med J; 1981 Feb; 57(664):84-8. PubMed ID: 6455656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A single infusion of bisphosphonate AHPrBP in the treatment of Paget's disease of bone.
    Chakravarty K; Merry P; Scott DG
    J Rheumatol; 1994 Nov; 21(11):2118-21. PubMed ID: 7869320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term treatment of Paget's disease of bone with salmon calcitonin.
    Sturtridge WC; Harrison JE; Wilson DR
    Can Med Assoc J; 1977 Nov; 117(9):1031-4. PubMed ID: 562231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.